All symbols in finviz (today's change): http://finviz.com/screener.ashx?v=211&ta=0&o=-change&t=GILD,AMGN,CELG,BIIB,REGN,ALXN,VRTX,ILMN,BMRN,INCY,JAZZ,MDVN,SGEN,QCOR,THRX,ALNY,TECH,NPSP,VPHM,CRL,AEGR,ACAD,CLDX,SNTS,IMGN,CLVS,GEVA,MNKD,HALO,ACOR,TSRO,LXRX,SRPT,ITMN,PDLI,PBYI,NKTR,VVUS,ARNA,EXEL,DYAX,CBPO,EBS,EXAS,INSY,INFI,OPTR,IDIX,ARRY,OSIR,CBM,ANAC,SPPI,SGMO,GERN,ARIA,NVAX,INSM,NLNK,CERS,HPTX,PRTA,CADX,PTCT,PLX,AMRI,ANIK,CMRX,DNDN,CGEN,ENTA,RGEN,XOMA,RPRX,PTLA,ECYT,EPZM,CRIS,INO,IMMU,SVA,BCRX,SNTA,ZIOP,CEMP,STML,OMER,SNSS,RCPT,PACB,CRTX,DRTX,XNPT,ACHN,RGLS,THLD,MACK,CLSN,ONCY,QLTI

No.
|
Ticker
|
Company
|
Market Cap
|
1
|
Gilead
Sciences Inc.
|
108.37B
|
|
2
|
Amgen Inc.
|
89.25B
|
|
3
|
Celgene
Corporation
|
62.66B
|
|
4
|
Biogen
Idec Inc.
|
57.73B
|
|
5
|
Regeneron
Pharmaceuticals, Inc.
|
27.92B
|
|
6
|
Alexion
Pharmaceuticals, Inc.
|
24.09B
|
|
7
|
Vertex
Pharmaceuticals Incorporated
|
14.96B
|
|
8
|
Illumina
Inc.
|
11.90B
|
|
9
|
BioMarin
Pharmaceutical Inc.
|
8.68B
|
|
10
|
Incyte
Corporation
|
5.75B
|
|
11
|
Jazz
Pharmaceuticals plc
|
5.29B
|
|
12
|
Medivation,
Inc.
|
4.99B
|
|
13
|
Seattle
Genetics Inc.
|
4.73B
|
|
14
|
Questcor
Pharmaceuticals, Inc.
|
3.59B
|
|
15
|
Theravance
Inc.
|
3.57B
|
|
16
|
Alnylam
Pharmaceuticals, Inc.
|
3.52B
|
|
17
|
Techne
Corp.
|
3.27B
|
|
18
|
NPS
Pharmaceuticals, Inc.
|
2.72B
|
|
19
|
ViroPharma
Inc.
|
2.55B
|
|
20
|
Charles
River Laboratories
International, Inc.
|
2.40B
|
|
21
|
Aegerion
Pharmaceuticals, Inc.
|
2.39B
|
|
22
|
ACADIA
Pharmaceuticals, Inc.
|
1.88B
|
|
23
|
Celldex
Therapeutics, Inc.
|
1.83B
|
|
24
|
Santarus,
Inc.
|
1.54B
|
|
25
|
Immunogen
Inc.
|
1.37B
|
|
26
|
Clovis
Oncology, Inc.
|
1.36B
|
|
27
|
Synageva BioPharma Corp.
|
1.36B
|
|
28
|
MannKind
Corp.
|
1.35B
|
|
29
|
Halozyme
Therapeutics, Inc.
|
1.30B
|
|
30
|
Acorda
Therapeutics, Inc.
|
1.23B
|
|
31
|
Tesaro,
Inc.
|
1.23B
|
|
32
|
Lexicon
Pharmaceuticals, Inc.
|
1.21B
|
|
33
|
Sarepta
Therapeutics, Inc.
|
1.20B
|
|
34
|
InterMune
Inc.
|
1.18B
|
|
35
|
PDL BioPharma, Inc.
|
1.15B
|
|
36
|
Puma
Biotechnology, Inc.
|
1.14B
|
|
37
|
Nektar
Therapeutics
|
1.09B
|
|
38
|
VIVUS Inc.
|
960.04M
|
|
39
|
Arena
Pharmaceuticals, Inc.
|
956.76M
|
|
40 |
EXEL |
Exelixis, Inc. |
914.39M |
41
|
Dyax Corp.
|
874.46M
|
|
42
|
China
Biologic Products, Inc.
|
789.49M
|
|
43
|
Emergent BioSolutions, Inc.
|
707.70M
|
|
44
|
Exact
Sciences Corporation
|
707.16M
|
|
45
|
INSYS
Therapeutics, Inc.
|
694.75M
|
|
46
|
Infinity
Pharmaceuticals, Inc.
|
635.85M
|
|
47
|
Optimer
Pharmaceuticals, Inc.
|
622.72M
|
|
48
|
Idenix
Pharmaceuticals Inc.
|
618.23M
|
|
49
|
Array BioPharma, Inc.
|
598.97M
|
|
50
|
Osiris
Therapeutics, Inc.
|
585.33M
|
|
51
|
Cambrex
Corporation.
|
519.34M
|
|
52
|
Anacor
Pharmaceuticals, Inc.
|
514.87M
|
|
53
|
Spectrum
Pharmaceuticals, Inc.
|
512.51M
|
|
54
|
Sangamo
Biosciences Inc.
|
509.35M
|
|
55
|
Geron
Corporation
|
504.96M
|
|
56
|
Ariad
Pharmaceuticals Inc.
|
476.59M
|
|
57
|
Novavax,
Inc.
|
463.03M
|
|
58
|
Insmed
Incorporated
|
462.34M
|
|
59
|
NewLink
Genetics Corporation
|
450.93M
|
|
60 |
CERS |
Cerus Corporation |
446.95M |
61
|
Hyperion
Therapeutics, Inc.
|
430.70M
|
|
62
|
Prothena
Corporation plc
|
428.86M
|
|
63
|
Cadence
Pharmaceuticals Inc.
|
424.73M
|
|
64
|
PTC
Therapeutics, Inc.
|
416.50M
|
|
65
|
Protalix BioTherapeutics, Inc.
|
412.58M
|
|
66
|
Albany
Molecular Research Inc.
|
406.28M
|
|
67
|
Anika
Therapeutics Inc.
|
400.33M
|
|
68
|
Chimerix,
Inc.
|
399.70M
|
|
69
|
Dendreon
Corp.
|
388.64M
|
|
70
|
Compugen
Ltd.
|
368.74M
|
|
71
|
Enanta
Pharmaceuticals, Inc.
|
359.07M
|
|
72
|
Repligen
Corporation
|
352.83M
|
|
73
|
XOMA
Corporation
|
349.17M
|
|
74
|
Repros
Therapeutics Inc.
|
341.43M
|
|
75
|
Portola
Pharmaceuticals, Inc.
|
337.69M
|
|
76
|
Endocyte,
Inc.
|
337.24M
|
|
77
|
Epizyme,
Inc.
|
330.72M
|
|
78
|
Curis Inc.
|
318.84M
|
|
79
|
Inovio
Pharmaceuticals, Inc.
|
314.92M
|
|
80 |
IMMU |
Immunomedics Inc. |
307.37M |
81
|
Sinovac
Biotech Ltd.
|
301.16M
|
|
82
|
BioCryst
Pharmaceuticals, Inc.
|
298.35M
|
|
83
|
Synta
Pharmaceuticals Corp.
|
294.78M
|
|
84
|
ZIOPHARM
Oncology, Inc.
|
290.79M
|
|
85
|
Cempra,
Inc.
|
284.66M
|
|
86
|
Stemline
Therapeutics, Inc.
|
281.73M
|
|
87
|
Omeros
Corporation
|
272.13M
|
|
88
|
Sunesis
Pharmaceuticals Inc.
|
260.22M
|
|
89
|
Receptos,
Inc.
|
257.12M
|
|
90
|
Pacific
Biosciences of California, Inc.
|
255.74M
|
|
91
|
Cornerstone Therapeutics Inc.
|
250.31M
|
|
92
|
Durata
Therapeutics, Inc.
|
246.16M
|
|
93
|
Xenoport,
Inc.
|
245.44M
|
|
94
|
Achillion
Pharmaceuticals, Inc.
|
244.35M
|
|
95
|
Regulus
Therapeutics Inc.
|
242.25M
|
|
96
|
Threshold
Pharmaceuticals Inc.
|
237.84M
|
|
97
|
Merrimack
Pharmaceuticals, Inc.
|
234.65M
|
|
98
|
Celsion
Corp.
|
233.34M
|
|
99
|
Oncolytics
Biotech Inc.
|
222.07M
|
|
100 |
QLTI |
QLT Inc. |
221.34M |
No comments:
Post a Comment